A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis
- Substances:–
Austria- Participants:18–64 years
- Sponsor:Zenas Biopharma (USA) LLC
Rare diseases
Investigational molecules
Locations
Waehringer Guertel 18-20, Alsergrund, 1090 Vienna, Austria
Medical University Of Vienna in Vienna, Austria specialises in clinical trials of conditions such as Crohn's disease, Non-small cell lung cancer, Breast cancer, Ovarian cancer, and other specialisations. This site conducts important research.
The division focuses on evaluating a novel HER3‑DXd in patients with advanced cancers that have spread to the central nervous system.
The studies are conducted at Medical University of Vienna with strong collaboration between academic investigators and commercial partners.
Clinical investigations address brain metastases arising from Metastatic Breast Cancer and Non‑Small Cell Lung Cancer, aiming to improve treatment outcomes inside the skull.
Over 184 investigators contribute to these trials, reflecting the site’s extensive expertise in neuro‑oncology.
A dedicated cohort investigates patients with solid tumors and untreated leptomeningeal disease, testing whether the HER3‑conjugate can extend survival.
The program highlights the department’s commitment to tackling rare and aggressive CNS complications of cancer.
Clinical trials currently enrolling participants at this site.
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
Austria
AustriaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.